Federal Judge Blocks Biden Administration’s Title IX Revision Nationwide ...

US generic competition for Johnson & Johnson’s (J&J) Zytiga (abiraterone) prostate cancer drug has moved a step closer after a court invalidated a key patent. J&J has said it will appeal against ...